Current Oncology Reports

Papers
(The TQCC of Current Oncology Reports is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
COVID-19 and Cancer: a Comprehensive Review193
Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?131
Clinical and Biological Features of Neuroendocrine Prostate Cancer99
Update on Osteosarcoma91
Targeting Apoptosis in Cancer70
Update on Management of Squamous Cell Esophageal Cancer67
Proteasome Inhibitor-Related Cardiotoxicity: Mechanisms, Diagnosis, and Management57
Cardiotoxicity of Immune Checkpoint Inhibitors53
The Immune Microenvironment in Head and Neck Squamous Cell Carcinoma: on Subsets and Subsites49
Advanced imaging techniques for neuro-oncologic tumor diagnosis, with an emphasis on PET-MRI imaging of malignant brain tumors49
Immunotherapy for Non-melanoma Skin Cancer47
New Insights into Mechanisms of Immune Checkpoint Inhibitor-Induced Cardiovascular Toxicity44
Immunotherapy in Cervical Cancer42
WEE1 Inhibitor: Clinical Development39
New Targets in Lung Cancer (Excluding EGFR, ALK, ROS1)38
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors38
Determination of Biological Age: Geriatric Assessment vs Biological Biomarkers37
The Landscape of Immunotherapy in Advanced NSCLC: Driving Beyond PD-1/PD-L1 Inhibitors (CTLA-4, LAG3, IDO, OX40, TIGIT, Vaccines)36
Giant Cell Tumor of Bone: An Update35
Bystander effect of antibody–drug conjugates: fact or fiction?35
A Review of the Current State of Hospice Care in China33
Gut Microbiome Modulation Via Fecal Microbiota Transplant to Augment Immunotherapy in Patients with Melanoma or Other Cancers33
Psychological Aspects to Consider in Breast Cancer Diagnosis and Treatment32
Post-Diagnostic Dietary and Lifestyle Factors and Prostate Cancer Recurrence, Progression, and Mortality31
Biological and Functional Biomarkers of Aging: Definition, Characteristics, and How They Can Impact Everyday Cancer Treatment30
Acute Myeloid Leukemia in Children: Emerging Paradigms in Genetics and New Approaches to Therapy30
First-Line Management of Advanced High-Grade Serous Ovarian Cancer29
Cognitive Behavioral and Mindfulness-Based Interventions for Smoking Cessation: a Review of the Recent Literature29
The COVID-19 Pandemic and its Impact on the Cardio-Oncology Population28
VEGF Receptor Inhibitor-Induced Hypertension: Emerging Mechanisms and Clinical Implications28
Emerging Therapeutics for Patients with Triple-Negative Breast Cancer28
Application of PET Tracers in Molecular Imaging for Breast Cancer27
Ependymoma: Evaluation and Management Updates27
Anaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics27
The Microbiome and Gynecologic Cancer: Current Evidence and Future Opportunities26
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies26
Targeting KRAS in Colorectal Cancer25
Disparities in Lung Cancer Treatment25
ROS1 Targeted Therapies: Current Status25
Management of Pigmented Villonodular Synovitis (PVNS): an Orthopedic Surgeon’s Perspective25
Sequencing Endocrine Therapy for Metastatic Breast Cancer: What Do We Do After Disease Progression on a CDK4/6 Inhibitor?25
Improving the Safety of Major Resection for Hepatobiliary Malignancy: Portal Vein Embolization and Recent Innovations in Liver Regeneration Strategies24
Vitamin D and Cancer Survival: Does Vitamin D Supplementation Improve the Survival of Patients with Cancer?24
Applying the New Guidelines of HER2 Testing in Breast Cancer24
Current Advances in Immunotherapy for Glioblastoma24
Present and Future of De-intensification Strategies in the Treatment of Oropharyngeal Carcinoma24
Bruton’s tyrosine kinase Inhibitors and Cardiotoxicity: More Than Just Atrial Fibrillation23
Fatty Acid Metabolism and Cancer Immunotherapy23
Multidisciplinary Outpatient Cancer Rehabilitation Can Improve Cancer Patients’ Physical and Psychosocial Status—a Systematic Review23
Engineered T Cells: CAR T Cell Therapy and Beyond23
FGFR Inhibitors: Clinical Activity and Development in the Treatment of Cholangiocarcinoma23
Anti-angiogenesis Revisited: Combination with Immunotherapy in Solid Tumors23
The Physical Consequences of Chemotherapy-Induced Peripheral Neuropathy22
New Checkpoint Inhibitors on the Road: Targeting TIM-3 in Solid Tumors22
Checkpoint Inhibitor Pneumonitis: Mechanisms, Characteristics, Management Strategies, and Beyond22
Mixed Phenotype Acute Leukemia: Current Approaches to Diagnosis and Treatment21
COVID and Lung Cancer21
Identifying and Meeting the Needs of Adolescents and Young Adults with Cancer21
The Treatment Landscape of Advanced Hepatocellular Carcinoma21
Microwave Ablation, Radiofrequency Ablation, Irreversible Electroporation, and Stereotactic Ablative Body Radiotherapy for Intermediate Size (3–5 cm) Unresectable Colorectal Liver Metastases: a System20
Prostate Cancer Immunotherapy—Finally in From the Cold?20
Surgical Approach to Lymphedema Reduction19
Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications19
Cardiovascular Toxicity of Novel HER2-Targeted Therapies in the Treatment of Breast Cancer19
Cardiac Biomarkers in Patients with Cancer: Considerations, Clinical Implications, and Future Avenues19
CAR-T Therapies in Solid Tumors: Opportunities and Challenges19
Hyperprogressive Disease upon Immune Checkpoint Blockade: Focus on Non–small Cell Lung Cancer18
Central Nervous System Involvement in Adults with Acute Leukemia: Diagnosis, Prevention, and Management18
Statins as Potential Chemoprevention or Therapeutic Agents in Cancer: a Model for Evaluating Repurposed Drugs18
Access to Therapy for Acute Myeloid Leukemia in the Developing World: Barriers and Solutions17
Cytokines in the Treatment of Melanoma17
Desmoid Fibromatosis: Management in an Era of Increasing Options17
The Management of rNPC: Salvage Surgery vs. Re-irradiation17
The Role of Malnutrition and Muscle Wasting in Advanced Lung Cancer17
Telemedicine in Cancer Care Beyond the COVID-19 Pandemic: Oncology 2.0?17
Hairy Cell Leukaemia17
Neutrophil Extracellular Trapping Role in Cancer, Metastases, and Cancer-Related Thrombosis: a Narrative Review of the Current Evidence Base17
Chemotherapy and Radiation-Associated Cardiac Autonomic Dysfunction16
IDH-Mutant Low-grade Glioma: Advances in Molecular Diagnosis, Management, and Future Directions16
DNA Repair Mechanisms and Therapeutic Targets in Glioma16
Cancer Screening Among Older Adults: a Geriatrician’s Perspective on Breast, Cervical, Colon, Prostate, and Lung Cancer Screening16
Management of the Small Renal Mass: a 2020 Update16
Richter Syndrome16
Role of Platinums in Triple-Negative Breast Cancer16
Advances in Molecular Classification and Therapeutic Opportunities in Meningiomas16
Updates in Cardiac Amyloidosis Diagnosis and Treatment16
Diagnostic and Therapeutic Considerations for Extramedullary Leukemia15
Management of the Neck in Well-Differentiated Thyroid Cancer15
Molecular Subgroups of Diffuse Large B Cell Lymphoma: Biology and Implications for Clinical Practice15
Current Clinical Trial Landscape of OX40 Agonists15
The Development of STING Agonists and Emerging Results as a Cancer Immunotherapy15
Neurological Complications of CAR T Cell Therapy15
Radiogenomics in Interventional Oncology15
Cancer Pain Management—New Therapies15
COVID-19 in Children with Cancer15
Clinical Development of Anti-TIGIT Antibodies for Immunotherapy of Cancer15
Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?15
Neurofibromatosis in the Era of Precision Medicine: Development of MEK Inhibitors and Recent Successes with Selumetinib15
Adult T-Cell Leukemia: a Comprehensive Overview on Current and Promising Treatment Modalities14
Management of Acute Myeloid Leukemia (AML) in Older Patients14
Management of Upper Tract Urothelial Carcinoma14
Review of New-Generation Tyrosine Kinase Inhibitors for Chronic Myeloid Leukemia14
Radiation-Induced Cardiovascular Disease: Mechanisms, Prevention, and Treatment14
Interventions that Facilitate Shared Decision-Making in Cancers with Active Surveillance as Treatment Option: a Systematic Review of Literature14
Progress Update in Pediatric Renal Tumors14
State of Rehabilitation Research in the Head and Neck Cancer Population: Functional Impact vs. Impairment-Focused Outcomes14
Approaches to Non-Muscle-Invasive Bladder Cancer14
Rare Breast Cancer Subtypes14
Role of Machine Learning and Artificial Intelligence in Interventional Oncology13
The Evolving Role of Radiation Therapy in Patients with Metastatic Soft Tissue Sarcoma13
CAR T-Cell Therapy in the Older Person: Indications and Risks13
Global Perspectives on Palliative Care for Cancer Patients: Not All Countries Are the Same13
Immune Checkpoint Inhibitor Rechallenge and Resumption: a Systematic Review13
Percutaneous Management of Cancer Pain13
Updates on Surgical Management and Advances for Brain Tumors13
Palliative and End-of-Life Care for Sexual and Gender Minority Cancer Survivors: a Review of Current Research and Recommendations13
Value and Quality of Care in Head and Neck Oncology13
Early Therapeutic Interventions for Newly Diagnosed Glioblastoma: Rationale and Review of the Literature13
Radiation Therapy and Mandibular Osteoradionecrosis: State of the Art13
Is There a Role for Percutaneous Ablation for Early Stage Lung Cancer? What Is the Evidence?12
Medulloblastoma: an Old Diagnosis with New Promises12
Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?12
Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?12
Current Approaches in Hepatoblastoma—New Biological Insights to Inform Therapy12
Cancer-Related Fatigue—Is There a Role for Complementary and Integrative Medicine?12
The Combined Use of SBRT and Immunotherapy—a Literature Review12
Isocitrate Dehydrogenase, Patient-Reported Outcomes, and Cognitive Functioning of Glioma Patients: a Systematic Review12
Locally Advanced Pancreatic Cancer: Percutaneous Management Using Ablation, Brachytherapy, Intra-arterial Chemotherapy, and Intra-tumoral Immunotherapy12
Global Perceptions of Women on Breast Cancer and Barriers to Screening12
Molecular Biomarkers in Sinonasal Cancers: New Frontiers in Diagnosis and Treatment12
Prehabilitative Exercise for the Enhancement of Physical, Psychosocial, and Biological Outcomes Among Patients Diagnosed with Cancer11
What Do We Currently Know About Chronic Myeloid Leukemia (CML) and COVID-19?11
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications11
Radiotherapy and Immunotherapy Combinations for Lung Cancer11
Combined BRAF-Targeted Therapy with Immunotherapy in BRAF-Mutated Advanced Melanoma Patients11
The Role and Impact of Minimal Residual Disease in NSCLC11
Induction Chemotherapy for Advanced Oral Cavity Cancer11
Racial Disparity in Response to Prostate Cancer Systemic Therapies11
Lymphoblastic Lymphoma: a Concise Review11
Reaching Across the Aisle: Cardio-Oncology Advocacy and Program Building11
Mitochondrial Inhibition: a Treatment Strategy in Cancer?11
Alternative Checkpoints as Targets for Immunotherapy11
What’s New in Percutaneous Ablative Strategies for Hepatocellular Carcinoma and Colorectal Hepatic Metastases? 2020 Update11
Immunology of Lynch Syndrome11
Triplet Therapy in Melanoma — Combined BRAF/MEK Inhibitors and Anti-PD-(L)1 Antibodies11
A New Generation of Vaccines in the Age of Immunotherapy11
Acute Leukemia in Infants11
Improving Breast Cancer Responses to Immunotherapy—a Search for the Achilles Heel of the Tumor Microenvironment11
Current Role of Functional Imaging in the Management of Lymphoma11
Older Patients with Acute Myeloid Leukemia Deserve Individualized Treatment11
Vitamin D in Head and Neck Cancer: a Systematic Review11
0.058129072189331